<DOC>
	<DOCNO>NCT02307071</DOCNO>
	<brief_summary>This study evaluate effect chronic migraine patient daily 20 minute-transcutaneous sub occipital neurostimulation use occipital CefalyÂ° device .</brief_summary>
	<brief_title>Occipital Transcutaneous Stimulation Chronic Migraine</brief_title>
	<detailed_description>Chronic migraine disable neurological condition affect 0.5-2 % population . CM difficult treat preventive treatment option limit . Due inefficiency available lack new preventive anti-migraine drug , neurostimulation method raise great interest recent year . The ONSTIM study show reduction headache frequency 39 % patient treat active ONS 12 week , compare improvement `` non-effectively '' stimulate medically treat group .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>diagnosis chronic migraine ( ICHD III beta 1.3 ) without medication overuse disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>